FindTrial
Sign In

Breakthrough for Overcoming Lymph Edema II

Breakthrough for Overcoming Lymph Edema II - BTOLE II

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000008247
Enrollment
15
Registered
2012-07-01
Start date
2012-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymph edema

Interventions

cilostazol 6 months 200 mg /2x self compression machine 6 months 20 minutes /day

Sponsors

Department of Cardiovascular Surgery, National Center for Global Health and Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: no responder in BTOLE I trial

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Grade of edema(circumferance and subcutaneous area of deseased limb on CT)—

Secondary

MeasureTime frame
Pain(VAS)—

Countries

Japan

Contacts

Public ContactNaomi Tanuma

National Center for Global Health and Medicine Department of Clinical Research Coadination

ntanuma-ncgm@hotmail.co.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026